About 269,000 results
Open links in new tab
US FDA approves GSK’s AREXVY, the world’s first respiratory …
US FDA approves expanded age indication for GSK’s AREXVY, the …
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
New data for AREXVY, GSK’s RSV vaccine, show potential to help …
About Arexvy (respiratory syncytial virus vaccine, adjuvanted) - GSK
RSV vaccine race heats up with highly effective GSK shot
GSK RSV vaccine shows potential to protect adults 50 to 59
‘A good day’: FDA approves world’s first RSV vaccine - Nature
RSV vaccines score landmark FDA approvals - Nature
FDA approves GSK RSV vaccine for adults 50 to 59 - CNBC